Skip to main content
Equibles
INO logo

INO · Inovio Pharmaceuticals, Inc. · Supply Chain

Track INO — free

Use INO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.02 +0.02 (+2.00%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We do not currently have sufficient working capital to fund our planned operations for the next twelve months and substantial doubt exists as to our ability to continue as a going concern.”
View the 10-Q filed Aug 12, 2026
Customer concentration — key customers 100% of revenue

Key customers — 100% of revenue (the years ended December 31, 2025 and 2024)

“During the years ended December 31, 2025 and 2024, we derived 100% of our revenue from ApolloBio.”
View the 10-K filed Mar 12, 2026
Market Cap
$103.40M
Shares
103.40M
Volume · Oct 20 1.01M Avg daily vol (3M) 4.06M

Supply Chain

Customers, suppliers, competitors and partners named in annual 10-K reports: INO's own, and those of other companies that name INO.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who INO sells to, buys from and competes with

  • 5 suppliers
  • 0 customers
  • 22 competitors

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1055726 CUSIP 45773H409 13F (30d) 14 filings 14 filers Visit website Investor relations